Preface
Part I: Introduction
Chapter 1. General Principles and Approach to Inpatient Dermatology
in;mso-hansi-theme-font:major-latin;mso-bidi-font-family: "Times New Roman"">DIVIDER
Part II: Medication reactions
Chapter 2. Morbilliform drug eruption
Chapter 3. Urticaria
ound-image: initial; Chapter 4. Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis
Chapter 5. Erythema
Multiforme
Chapter 6. Drug Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms
Chapter 7. Acute Generalized Exanthematous Pustulosis
pt;line-height: 115.0%;Chapter 8. Fixed Drug Eruption
oNormal">Chapter 9. Serum Sickness-like Reaction
DIVIDER
Part III. Oncodermatology: Cancer- and treatment-related skin issues
uot;,"serif";mso-ascii-theme-font:major-latin;mso-hansi-theme-font: major-latin;mso-bidi-Chapter 10. Sweet Syndrome
Chapter 11. Leukemia Cutis
ily: Cambria , serif;">Chapter 12. Toxic Erythema of Chemotherapy
aChapter 13. Neutrophilic Eccrine Hidradenitis
Chapter 14. Transient acantholytic dermatosis
pan style="font-size: 9pt; line-height: 115%; font-family: Cambria, serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> of Chemotherapy
amily: Cambria , serif;">Chapter 15.
repeat: initial; background-attachment: initial; background-origin: initial; background-clip: Serpentine Supravenous Hyperpigmentation
Chapter 16. Epidermal Growth Fa
ctor Inhibitors
Chapter 17. Bleomycin-induced flagellate erythema
bidi-font-family: "Times New Roman"">
9.0pt;line-Chapter 18. Graft-Versus-Host Disease: Acute
e: 9.0pt;line-heiChapter 19. Graft-Versus-Host Disease: Chronic
DIVIDER
t-size:9.0pt;line-height:115%; font-family:"Cambria","serif";mso-ascii-theme-font:major-latin;mso-hansi-theme-font: major-latin">[KH1]
Infections and Infestations
Part IV. Infections: Bacterial
ine-height: 115.0%;font-family: Cambria , serif;">Chapter 20. Superficial Staphylococcal and Streptococcal Infections
New Roman";mso-bidi-theme-font:major-bidi; background:yellow;mso-highlight:yellow">
Chapter 21. Cellulitis
Chap
ter 22. Necrotizing fasciitis
Chapter 23. Staphylococcal scalded skin syndrome
st-font-family: "Times New Roman";mso-fareast-theme-font:major-fareast;mso-hansi-theme-font: major-latin;mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi; mso-ansi-lang
class="MsoNormal">Chapter 24. Echthyma Gangrenosum
mes New Roman";mso-bidi-theme-font:major-bidi; mso-ansi-languageChapter 25. Purpura Fulminans
Chapter 26. Meningococcal Infections
Chapter 27.
yle="font-size: 9pt; line-height: 115%; font-family: Cambria, serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Atypical mycobacteria
al">
mes New Roman";msoChapter 28. Lyme disease
Chapter 29. Spotted Fever
Chapter 30. Syphilis
="MsoNormal">
Part V. Infections: Viral
Chapter 31. Herpes simplex virus
amily: Cambria , serif;">Chapter 32. Eczema Herpeticum
font-size:9.0pt;line-height:115%; font-family:"Cambria","serif";mso-ascii-theme-font:major-latin;mso-hansi-theme-font: major-latin;mso-bidi-font-family:"Times New Roman";mso-ansi-language:Chapter 33. Varicella zoster virus
Chapter 34. Coxsackie virus: Hand-Foot-Mouth Disease
Chapter 35.
: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Human Immunodeficiency Virus
mbria , serif;">Chapter 36. Kaposi’s Sarcoma
="FR" style="font-size:9.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-foPart VI. Infections: Fungal
Chapter 37. Superficial Dermatophyte / Tinea
Chapter 38. Candidiasis
ine-height:115%; font-family:"Cambria","serif";mso-ascii-theme-font:major-latin;mso-hansi-theme-font: major-latin;mso-bidi-font-family:"Times New Roman";mso-ansi-language:FR">Chapter 39. Angioinvasive Fungal infections
Chapter 40. Histoplas
mosis
Chapter 41. Coccidiodomycosis
ot;Cambria","serif";mso-ascii-theme-font:major-latin;mso-hansi-theme-font: major-latin;mso-bidi-font-family:"TimesChapter 42. Blastomycosis
Chapter 43. Cryptococcosis
Part VII. Infections: Ectoparasitic Infestations
erif";mso-ascii-theme-font:major-latin;mso-hansi-theme-font: major-latin;mso-bidi-font-family:"Times New Roman";mso-ansi-language:FR">Chapter 44. Scabies
Chapter 45. Lice
Chapter 46. Be
d Bugs
/p>
eight:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: "Times New Roman";mso-ansi-language:FR">DIVIDER
Part VIII. Purpura: Vasculitis and Vasculopathy
i-font-family:Arial;mso-ansi-language: FR">
t: 115.0%;font-family: Cambria , serif;">Chapter 47. Leukocytoclastic Vasculitis / Cutaneous small vessel vasculi
tis
>
pChapter 48. Granulomatosis with Polyangiitis
me-font:major-latin; mso-bidi-font-family:"Times New Roman"Chapter 49. Eosinophilic Granulomatosis with Polyangiitis
Chapter 50. Microscopic Polyangiitis
New Roman";mso-fareast-theme-font:major-fareast; mso-hansi-theme-font:major-latin;mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi">
Chapter 51.
if;">Pol
yarteritis Nodosa
soNormal">Chapter 52. Giant Cell Arteritis
Chapter 53. Cholesterol Emboli
Chapter 54.
rif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Infective Endocarditis
, serif;">Chapter 55. Cryoglobulinemia
">;
t: major-latin;mso-bidi-font-family:"Times New Roman";mso-ansi-language:FRChapter 56. Antiphospholipid Antibody Syndrome
Chapter 57. Calciphylaxis
Chapter 58.
rigin: initial; background-clip: initial;">Levamisole-Associat
DIVIDER
Part IX. Erythoderma
MsoNormal">t: 115.0%;font-family: Cambria , serif;">Chapter 59. ">Medication-Induced Erythroderma
">"font-size: 9.0pt;line-height: 115.0%;font-family: Cambria , serif;">Chapter 60. Atopic Dermatitis and Erythroderma
major-latin;mso-hansi-theme-font: major-latin;mso-bidi-font-family:"Times New Roman";mso-ansi-language:FR">Chapter 61. Psoriasis
: 115.0%;font-family: Cambria , serif;">Chapter 62. Cutaneous T-Cell Lymphoma
Chapter 63.
tial; background-origin: initial; background-clip: initial;">Pityriasis Rubra Pilaris
R" styDIVIDER
; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: "Times New Roman";mso-ansi-language:FR">Part X. Inflammatory and Autoimmune Conditions
;">
idi-foChapter 64. Pyoderma Gangrenosum
Chapter 65. Panniculitis / Erythema nodosum
Chapter 66. Lichen Planus
uot;,"serif";mso-ascii-theme-font:major-latin;mso-hansi-theme-font: major-latin;mso-bidi-font-family:"Times New Roman";mso-ansi-language:FR">Chapter 67. Dermatomyositis
">="FR" style="font-size: 9.0pt;line-height: 115.0%;font-family: Cambria , serif;">Chapter 68. Lupus
Chapter 69.
es New Roman"">Bullous Pemphigoid
Chapter 70. Pemphigus Foliaceus
Chapter 71. Pemphigus Vulgaris
Chapter 72.
Roman";mso-bidi-theme-font:major-bidi">Chapter 73. Dermatitis Herpetiformis
ine-height: 115.0%;font-family: Cambria , serif;">Chapter 74. Systemic Sclerosis
Chap
ter 75. Systemic Amyloidosis
di-font-family:"Times New Roman"">
DIVIDER
Part XI: Hospital-Related Skin Problems
Times New Roman"; mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial">
style="font-size: 9.0pt;line-heigh
%;font-family: Cambria , serif;">Chapter 76. Stasis Dermatitis
t: 115.0%;font-family: Cambria , serif;">Chapter 77. Miliaria
ine-height:115%;font-family: "Cambria","serif";mso-ascii-theme-fontChapter 78. Decubitus Ulcers
Chapter 79. Inte
rtrigo
Chapter 80. Contact Dermatitis
i-font-family:"Times New Roman"">Chapter 81. Edema Blisters
Chapter 82. Steroid Acne
